Alembic Pharma gets USFDA final approval for Brexpiprazole Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg and 4 mg Read more
Vitafoods India 2025 – Redefining and connecting the nutraceutical ecosystem to drive growth and sustainability in the industry Read more
FDA accepts Eisai’s BLA for LEQEMBI subcutaneous autoinjector for alzheimer’s disease treatment Read more